Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells-Reference-Cited by-同舟云学术

Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells

Published:2024-05 Issue:5 Volume:5 Page:101526
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Yoshikawa Toshiaki,Ito Yusuke,Wu Zhiwen,Kasuya Hitomi,Nakashima Takahiro,Okamoto Sachiko,Amaishi Yasunori,Zhang Haosong,Li Yang,Matsukawa Tetsuya,Inoue Satoshi,Kagoya Yuki^ORCID

Funder

Japan Society for the Promotion of Science

Princess Takamatsu Cancer Research Fund

Japan Agency for Medical Research and Development

Japan Science and Technology Agency Fusion Oriented REsearch for disruptive Science and Technology

Kobayashi Foundation for Cancer Research

Uehara Memorial Foundation

Cell Science Research Foundation

Aichi Cancer Center Research Institute

Astellas Foundation for Research on Metabolic Disorders

Takeda Science Foundation

SGH Foundation

Otsuka Toshimi Scholarship Foundation

Publisher

Elsevier BV

Reference69 articles.

1. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia;Maude;N. Engl. J. Med.,2018

2. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial;Locke;Lancet Oncol.,2019

3. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study;Abramson;Lancet,2020

4. KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma;Wang;N. Engl. J. Med.,2020

5. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma;Munshi;N. Engl. J. Med.,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing cytokines to optimize chimeric antigen receptor-T cell therapy for gastric cancer: Current advances and innovative strategies;Biomedicine & Pharmacotherapy;2024-09

2. Advancing CAR T-cell therapies: Preclinical insights and clinical translation for hematological malignancies;Blood Reviews;2024-09